Evergreen Capital Management LLC Bristol Myers Squibb CO Transaction History

Evergreen Capital Management LLC

  • $2.47 Billion
  • Q1 2024

A detailed history of Evergreen Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Evergreen Capital Management LLC holds 236,020 shares of BMY stock, worth $9.8 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
236,020
Previous 219,803 7.38%
Holding current value
$9.8 Million
Previous $11.3 Million 13.49%
% of portfolio
0.52%
Previous 0.48%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$47.98 - $54.4 $778,091 - $882,204
16,217 Added 7.38%
236,020 $12.8 Million
Q4 2023

Feb 14, 2024
BUY
$48.48 - $57.85 $874,724 - $1.04 Million
18,043 Added 8.94%
219,803 $11.3 Million
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $417,213 - $466,509
7,207 Added 3.7%
201,760 $11.7 Million
Q2 2023

Aug 14, 2023
BUY
$63.71 - $70.74 $287,586 - $319,320
4,514 Added 2.38%
194,553 $12.4 Million
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $281,304 - $319,062
4,281 Added 2.3%
190,039 $13.2 Million
Q4 2022

Feb 14, 2023
BUY
$68.48 - $81.09 $77,108 - $91,307
1,126 Added 0.61%
185,758 $13.4 Million
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $178 - $105,501
1,373 Added 0.75%
184,632 $13.1 Million
Q2 2022

Aug 15, 2022
SELL
$72.62 - $79.98 $6.1 Million - $6.72 Million
-84,017 Reduced 31.43%
183,259 $14.2 Million
Q1 2022

May 16, 2022
SELL
$61.48 - $73.72 $2.4 Million - $2.88 Million
-39,087 Reduced 12.76%
267,276 $19.5 Million
Q4 2021

Mar 11, 2022
BUY
$53.63 - $62.52 $671,930 - $783,313
12,529 Added 4.26%
306,363 $19.1 Million
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $2.57 Million - $3.01 Million
43,442 Added 17.35%
293,834 $17.4 Million
Q2 2021

Aug 16, 2021
BUY
$61.91 - $67.42 $508,528 - $553,787
8,214 Added 3.39%
250,392 $16.7 Million
Q1 2021

May 17, 2021
BUY
$59.34 - $66.74 $6.4 Million - $7.2 Million
107,834 Added 80.27%
242,178 $15.3 Million
Q4 2020

Feb 16, 2021
BUY
$57.74 - $65.43 $347,941 - $394,281
6,026 Added 4.7%
134,344 $8.33 Million
Q3 2020

Nov 16, 2020
BUY
$57.43 - $63.64 $89,648 - $99,342
1,561 Added 1.23%
128,318 $7.74 Million
Q2 2020

Aug 14, 2020
BUY
$54.82 - $64.09 $199,654 - $233,415
3,642 Added 2.96%
126,757 $7.45 Million
Q1 2020

May 15, 2020
BUY
$46.4 - $67.43 $2.82 Million - $4.09 Million
60,714 Added 97.3%
123,115 $6.86 Million
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $1.14 Million - $1.48 Million
23,069 Added 58.65%
62,401 $4.01 Million
Q3 2019

Nov 14, 2019
BUY
$42.77 - $50.71 $2,437 - $2,890
57 Added 0.15%
39,332 $2 Million
Q2 2019

Aug 14, 2019
BUY
$44.62 - $49.34 $1.22 Million - $1.35 Million
27,384 Added 230.29%
39,275 $1.78 Million
Q1 2019

May 10, 2019
SELL
$45.12 - $53.8 $52,384 - $62,461
-1,161 Reduced 8.9%
11,891 $567,000
Q4 2018

Feb 14, 2019
BUY
$48.76 - $63.23 $133,407 - $172,997
2,736 Added 26.52%
13,052 $678,000
Q3 2018

Nov 13, 2018
SELL
$55.19 - $62.25 $21,524 - $24,277
-390 Reduced 3.64%
10,316 $640,000
Q2 2018

Aug 13, 2018
SELL
$50.53 - $62.98 $51,237 - $63,861
-1,014 Reduced 8.65%
10,706 $592,000
Q1 2018

May 10, 2018
BUY
$59.92 - $68.98 $156,091 - $179,692
2,605 Added 28.58%
11,720 $741,000
Q4 2017

Feb 14, 2018
SELL
$59.94 - $65.35 $119,160 - $129,915
-1,988 Reduced 17.91%
9,115 $558,000
Q3 2017

Nov 09, 2017
BUY
$55.23 - $63.74 $613,218 - $707,705
11,103
11,103 $708,000

Others Institutions Holding BMY

# of Institutions
2,554
Shares Held
1.49B
Call Options Held
25.9M
Put Options Held
20M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $88.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Evergreen Capital Management LLC Portfolio

Follow Evergreen Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email